Inactive Instrument

Quotient Limited OTC Markets

QTNT

JE00BNNSZY03

Quotient Limited(NasdaqGM:QTNT) dropped from S&P TMI Index

January 05, 2023 at 10:30 am IST

Latest news about Quotient Limited

Quotient Limited Appoints James Harman Gaudin to its Board of Directors	14/23/14	CI
Certain Ordinary Shares of Quotient Limited are subject to a Lock-Up Agreement Ending on 23-SEP-2022.	23/22/23	CI
Certain Restricted Share Units of Quotient Limited are subject to a Lock-Up Agreement Ending on 23-SEP-2022.	23/22/23	CI
Certain Options of Quotient Limited are subject to a Lock-Up Agreement Ending on 23-SEP-2022.	23/22/23	CI
Certain Warrants of Quotient Limited are subject to a Lock-Up Agreement Ending on 23-SEP-2022.	23/22/23	CI
Transcript : Quotient Limited, Q4 2022 Earnings Call, Jun 24, 2022	24/22/24
Quotient Limited Provides Earnings Guidance for the Fiscal Year 2023	24/22/24	CI

Quotient Limited is a Switzerland-based diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).

Sector

Pharmaceuticals

More about the company